Yaron Silberman - Medigus Chief Ltd
| MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Insider
Yaron Silberman is Chief Ltd of Medigus Ltd ADR
| Age | 54 |
| Phone | 972 73 370 4691 |
| Web | https://www.medigus.com |
Medigus Management Efficiency
The company has return on total asset (ROA) of (0.0663) % which means that it has lost $0.0663 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3072) %, meaning that it created substantial loss on money invested by shareholders. Medigus' management efficiency ratios could be used to measure how well Medigus manages its routine affairs as well as how well it operates its assets and liabilities.Medigus Ltd ADR currently holds 10.13 M in liabilities with Debt to Equity (D/E) ratio of 0.27, which may suggest the company is not taking enough advantage from borrowing. Medigus Ltd ADR has a current ratio of 1.35, which is within standard range for the sector. Note, when we think about Medigus' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Christopher Jako | Brainsway | 55 | |
| Michael Goodman | STRATA Skin Sciences | N/A | |
| Naum Muchnik | Icecure Medical | 48 | |
| John MS | Delcath Systems | 63 | |
| Brendan Shook | Paragon 28 | N/A | |
| David MD | Nexalin Technology | 62 | |
| Kevin Vance | Bluejay Diagnostics | 66 | |
| Mark Knudson | ReShape Lifesciences | 75 | |
| Kevin Muir | Delcath Systems | N/A | |
| William MD | Nuwellis | N/A | |
| Krissy Wright | Paragon 28 | N/A | |
| Nikolai Kabelev | STRATA Skin Sciences | 48 | |
| Marilyn Elson | Nexalin Technology | 71 | |
| Jason Edie | Paragon 28 | N/A | |
| Laurent Duhoux | Nuwellis | N/A | |
| Christopher Jako | BrainsWay | 54 | |
| Ronen CPA | Icecure Medical | 55 | |
| Joel Bradus | Nexalin Technology | N/A | |
| Shay Levav | Icecure Medical | 47 | |
| Lee Rosenthal | Paragon 28 | N/A | |
| MS MBA | Delcath Systems | 61 | |
Management Performance
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0663 |
Medigus Ltd ADR Leadership Team
Elected by the shareholders, the Medigus' board of directors comprises two types of representatives: Medigus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medigus. The board's role is to monitor Medigus' management team and ensure that shareholders' interests are well served. Medigus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medigus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ilan Oren, Executive Officer | ||
| Yaron Silberman, Chief Ltd | ||
| Liron Carmel, Chief Officer | ||
| Tali Dinar, Chief Officer |
Medigus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medigus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0663 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 65.3 M | |||
| Shares Outstanding | 1.89 M | |||
| Shares Owned By Institutions | 0.29 % | |||
| Number Of Shares Shorted | 4.18 K | |||
| Price To Earning | 33.86 X | |||
| Price To Book | 0.15 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |